Abstract:Abstract Background The etiology of Alzheimer’s disease (AD) is currently unknown, but several risk factors have been associated with AD including infectious agents. The central nervous system (CNS) is continuously monitored by immune cells, many of which circulate through the cerebrospinal fluid and the meninges. Meningeal immune cells respond to CNS‐intrinsic perturbations, such as neuroinflammation or neurodegeneration as well as to CNS‐extrinsic challenges, such as systemic infection. The goal of the study is to analyze the profile of meningeal immune cells and T cell clonality in AD in comparison with other neurodegenerative diseases. Method We used single‐cell RNA and T‐cell receptor (TCR) sequencing to characterize CD45+ immune cells from fresh leptomeninges from AD, Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Result We identified multiple myeloid and lymphoid clusters in all neurodegenerative samples including meningeal macrophages expressing CD14 and C1QA and the resident meningeal macrophage marker LYVE‐1. Lymphoid populations represented the majority of total cells and were composed of both CD8+ effector memory T‐cells and a mixed population of NK cells and NK‐like T‐cells. Ligand/receptor network analyses identified several significant intercellular interactions including osteopontin signaling between meningeal macrophages and both clonally expanded cytotoxic CD8 T and NK/NK‐like T‐cells. TCR sequence analysis revealed up to 500 unique TCR clonotypes in each sample, many of which were hyperexpanded with 25‐50% of the TCR repertoire being occupied by the top 20 clonotypes and some of which had high TCRa chain sequence homology to EBV‐specific TCRs. Conclusion We provide evidence for disrupted myeloid homeostasis and broad T‐cell clonal expansion in the leptomeninges of AD patients. Network analyses suggest that meningeal macrophages in neurodegeneration may promote long‐term clonally expanded T‐cell survival through osteopontin signaling. These data recapitulate findings across several animal studies and will be useful in developing immunomodulatory interventions to treat neurodegeneration.

Enrichment of liver MAIT cells in a mouse model of Alzheimer's disease

Levation of serum macrophage colony stimulating factor level in patients with Alzheimer's disease

Liver Bile Acid Changes in Mouse Models of Alzheimer’s Disease

Abstract WP291: Cerebral Amyloid Angiopathy Induces Liver Inflammation in Aged Mice

CNS Immune Surveillance in Alzheimer’s Disease

Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice

Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function

Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease

Age- and sex-dependent alterations in the peripheral immune system in the 3xTg-AD mouse model of Alzheimer's disease: Increased proportion of CD3+CD4-CD8- double-negative T cells in the blood

Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer's Disease

Innate and Adaptive Immune Basis of Mental Health Effect on Alzheimer’s Disease Progression

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease

Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer's Disease

Altered T cell reactivity to β-amyloid-related antigens in early Alzheimer's disease

Immune Activation in Alzheimer Disease

Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells

Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease

CD11a expression distinguishes infiltrating myeloid cells from plaque-associated microglia in Alzheimer's disease

Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease

Supplementary Data from Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma